Advertisement


Zydus
India  /  Published 22.08.21

Zydus readies for output challenge

Zydus Cadila expects to produce 30 to 40 million doses of its Covid-19 vaccine by December instead of the 50 million doses the Centre hoped to receive from the Ahmedabad-based maker of India’s f...
By G.S. Mudur in New Delhi

India  /  Published 21.08.21

Covid: Zydus jab from September

Drug firm Zydus Cadila on Saturday said it is looking to supply its Covid-19 vaccine ZyCoV-D by the middle to end of September, adding the pricing of the dose will be announced in the next one or two ...
By Our Bureau, PTI in New Delhi

India  /  Published 20.08.21

First jab for kids gets DCGI nod

Indigenously developed Zydus Cadila COVID-19 vaccine ZyCoV-D has received approval for Emergency Use Authorisation from the Drug Controller General of India and it will be administered to people 12 ye...
By Our Bureau, PTI in New Delhi

India  /  Published 24.07.21

Jabs for children by September

Children are likely to get their vaccines by September, AIIMS chief Dr Randeep Guleria said on Saturday, explaining that it will be a significant move to break the chain of Covid-19 tra...
By Our Bureau in New Delhi

India  /  Published 02.07.21

Zydus seeks vaccine nod, hope for kids

...
By G.S. Mudur in New Delhi

Advertisement

India  /  Published 01.07.21

Jabs: Zydus seeks emergency nod

Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Drug Controller General of India (DCGI) for its COVID-19 vaccine ZyCoV-D. The company said it has conducted...
By Our Bureau, PTI in New Delhi

India  /  Published 26.06.21

Covid: Zydus Cadila jab for 12-18 soon, says govt

A new coronavirus vaccine developed by Indian pharmaceutical company Zydus Cadila will be available soon for the young between 12-18, the central government said in an affidavit to the Supreme Court o...
By Our Bureau, Agencies in New Delhi

Business  /  Published 13.05.21

Tatas seal deal to buy 1mg

A consortium led by Multiples Alternate Asset Management is acquiring the animal health business of Zydus Cadila in India and certain other countries for Rs 2,921 crore. Multiples along with Canada P...
By Our Special Correspondent in Mumbai

India  /  Published 23.04.21

DCGI nod to Zydus Covid drug

Drug firm Zydus Cadila on Friday said it has received restricted emergency use approval from the Indian drug regulator for the use of Pegylated Interferon alpha-2b (PegIFN) in treating moderate Covid-...
By Our Bureau, Agencies in New Delhi

India  /  Published 28.11.20

Vaccine: PM tours 3 pharma firms

Prime Minister Narendra Modi visited  Hyderabad, Ahmedabad and Pune on Saturday to take the stock of Covid-19 vaccine development in the cities. The Prime Minister’s Office  (PMO) sai...
By Our Bureau, Agencies in New Delhi


Advertisement

Download our latest App

to get update on the go...

Advertisement

Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.